cbdMD, Inc. (YCBD)
AMEX·Healthcare·Drug Manufacturers - Specialty & Generic
$0.93
-4.10%
Mkt Cap $7.91M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | $4.86M | $5.02M | +3.27% | -$0.06 | -$0.04 | +33.33% | — | — |
| Q4 2025 Dec 19, 2025 | $4.70M | $4.72M | +0.40% | -$0.07 | -$0.08 | -8.93% | — | — |
| Q3 2025 Aug 14, 2025 | $4.70M | $4.61M | -2.02% | -$0.02 | -$0.21 | -950.00% | — | — |
| Q2 2025 May 15, 2025 | $5.14M | $4.75M | -7.63% | -$1.60 | -$1.90 | -18.75% | — | — |
| Q1 2025 Feb 13, 2025 | $5.19M | $5.11M | -1.42% | -$0.37 | -$1.76 | -375.68% | — | — |
| Q4 2024 Dec 27, 2024 | — | $4.56M | — | — | -$9.06 | — | — | — |
| Q3 2024 Aug 14, 2024 | $4.81M | $5.17M | +7.57% | -$0.62 | -$1.20 | -93.55% | — | — |
| Q2 2024 May 15, 2024 | $5.40M | $4.38M | -18.95% | -$0.75 | -$10.80 | -1340.00% | — | — |
| Q1 2024 Feb 13, 2024 | $5.80M | $5.38M | -7.32% | -$0.74 | -$5.36 | -624.32% | — | — |
| Q1 2024 Jan 29, 2024 | — | $5.71M | — | -$0.74 | -$0.67 | +9.46% | — | — |
| Q3 2023 Aug 10, 2023 | $13.80M | $6.12M | -55.66% | -$21.60 | -$9.28 | +57.04% | — | — |
| Q2 2023 May 15, 2023 | $12.00M | $6.24M | -48.00% | -$28.80 | -$13.92 | +51.67% | — | — |
| Q1 2023 Feb 13, 2023 | $11.50M | $6.09M | -47.09% | -$15.75 | -$28.83 | -83.05% | — | — |
| Q4 2022 Dec 15, 2022 | $11.00M | $7.86M | -28.55% | -$1.35 | -$90.09 | -6573.33% | — | — |
| Q3 2022 Aug 11, 2022 | $10.50M | $8.59M | -18.16% | -$2.25 | -$7.21 | -220.44% | — | — |
| Q2 2022 May 13, 2022 | $10.00M | $9.63M | -3.71% | -$4.05 | -$36.04 | -789.88% | — | — |
| Q1 2022 Feb 10, 2022 | $13.25M | $9.32M | -29.65% | -$11.53 | -$14.41 | -25.00% | — | — |
| Q4 2021 Dec 17, 2021 | $11.25M | $9.79M | -12.95% | — | -$14.41 | — | — | — |
| Q3 2021 Aug 12, 2021 | $13.10M | $10.56M | -19.39% | -$0.01 | -$0.01 | -75.13% | — | — |
| Q2 2021 May 12, 2021 | $63.71M | $11.80M | -81.48% | -$10.81 | -$86.49 | -700.00% | — | — |